News

Accelera and BiomimX: Commercial agreement
Nerviano, 30 June 2021 Accelera Srl and BiomimX® Srl have signed a non-exclusive commercial agreement following an intense scientific collaboration aimed at introducing and applying new technological solutions to the drug discovery process. The...
Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition
Nerviano, 17 May 2021 The relationship between Accelera and CROss Alliance® started a decade ago and since then we have renewed our collaboration during the years. Our specializations, preclinical and early phase clinical development respectively, our shared...